
    
      After being informed about the study and potential risks, all eligible patients giving
      written informed consent will undergo a comprehensive non-invasive assessment of vascular and
      cardiac function 6 months and 12 months after COVID-19 infection. Cardiovascular events and
      mortality will be collected 2, 5 and 10 years after inclusion
    
  